ChiCTR2600124768 版本V1.0 版本创建时间2026/05/18 09:08:02 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600124768 

最近更新日期:

Date of Last Refreshed on:

2026-05-18 09:06:57 

注册时间:

Date of Registration:

2026-05-18 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

远程运动处方在慢性腰痛患者中的疗效分析

Public title:

Analysis of the efficacy of remote exercise prescription in patients with chronic low back pain

注册题目简写:

English Acronym:

研究课题的正式科学名称:

远程运动处方在慢性腰痛患者中的疗效分析

Scientific title:

Analysis of the efficacy of remote exercise prescription in patients with chronic low back pain

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

贾杰 

研究负责人:

贾杰 

Applicant:

Jia Jie 

Study leader:

Jia Jie 

申请注册联系人电话:

Applicant telephone:

+86 21 5288 7820

研究负责人电话:

Study leader's
telephone:

+86 21 5288 7820

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

shannonjj@126.com

研究负责人电子邮件:

Study leader's E-mail:

shannonjj@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市西康路259号

研究负责人通讯地址:

上海市西康路259号

Applicant address:

No. 259 Xikang Road, Shanghai

Study leader's address:

No. 259 Xikang Road, Shanghai

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海市静安区中心医院

Applicant's institution:

Shanghai Jing'an District Central Hospital

研究负责人所在单位:

上海市静安区中心医院

Affiliation of the Leader:

Shanghai Jing'an District Central Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2026-21

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海市静安区中心医院医学伦理委员会

Name of the ethic committee:

Ethics Committee OF Jing'an District Central Hospital Of Shanghai

伦理委员会批准日期:

Date of approved by ethic committee:

2026-04-08 00:00:00

伦理委员会联系人:

顾北令

Contact Name of the ethic committee:

Gu Beiling

伦理委员会联系地址:

上海市西康路259号

Contact Address of the ethic committee:

No. 259 Xikang Road, Shanghai

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 21 61578078

伦理委员会联系人邮箱:

Contact email of the ethic committee:

jzxywb1@126.com

研究实施负责(组长)单位:

上海市静安区中心医院

Primary sponsor:

Jing'an District Central Hospital of Shanghai

研究实施负责(组长)单位地址:

上海市西康路259号

Primary sponsor's address:

No. 259 Xikang Road, Shanghai

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海市

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市静安区中心医院

具体地址:

上海市西康路259号

Institution
hospital:

Jing'an District Central Hospital of Shanghai

Address:

No. 259 Xikang Road, Shanghai

经费或物资来源:

自筹

Source(s) of funding:

self-funded

研究疾病:

慢性腰痛  

Target disease:

Chronic lower back pain

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1.观察远程运动处方对慢性腰痛患者疼痛、腰椎功能、腰椎活动度、心理状态、生活质量的改善效果。 2.为慢性腰痛患者提供一种可推广、低成本、高依从的居家远程康复模式。  

Objectives of Study:

1.To evaluate the efficacy of the remote exercise prescription in improving pain, lumbar function, range of motion; 2.To provide a scalable, cost-effective, and high-adherence home-based tele-rehabilitation model for patients with chronic low back pain.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.年龄25~50岁,性别不限; 2.自愿参与试验并签署知情同意书; 3.反复腰痛持续3个月以上; 4.会使用智能手机。

Inclusion criteria

1.Aged between 25 and 50 years, regardless of gender.
2.Willing to participate in the study and sign the informed consent form.
3.Recurrent low back pain lasting for more than 3 months.
4.Proficiency in using a smartphone.

排除标准:

1.合并有严重的心脑、呼吸、消化、免疫、神经、内分泌、血液等系统损害者; 2.有精神、神经系统疾病患者不能配合者; 3.妊娠期妇女。

Exclusion criteria:

1. Those with severe damage to the heart, brain, respiratory, digestive, immune, nervous, endocrine, blood, and other systems; 2. Patients with mental or nervous system disorders who cannot cooperate; 3. Pregnant women.

研究实施时间:

Study execute time:

From 2026-05-28 00:00:00 To 2027-05-28 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-05-28 00:00:00 To 2027-05-28 00:00:00

干预措施:

Interventions:

组别:

视频居家组

样本量:

25

Group:

Video-based Home Group

Sample size:

干预措施:

远程运动处方

干预措施代码:

Intervention:

Tele-exercise Prescription

Intervention code:

组别:

纸质居家组

样本量:

25

Group:

Paper-based Home Group

Sample size:

干预措施:

纸质运动处方指导

干预措施代码:

Intervention:

Paper-based exercise prescription guide

Intervention code:

组别:

临床面对面组

样本量:

25

Group:

Face-to-face Clinical Group

Sample size:

干预措施:

临床面对面运动处方指导

干预措施代码:

Intervention:

Face-to-face clinical exercise prescription guidance

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海市 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市静安区中心医院 

单位级别:

三级乙等 

Institution
hospital:

Jing'an District Central Hospital Of Shanghai

Level of the institution:

Tertiary B

测量指标:

Outcomes:

指标中文名:

Zung 焦虑自我评定量表评分

指标类型:

次要指标

Outcome:

Zung Self-Rating Anxiety Scale Score

Type:

Secondary indicator

测量时间点:

干预前,干预4周,干预8周

测量方法:

Measure time point of outcome:

baseline, week 4, and week 8

Measure method:

指标中文名:

TUG测试

指标类型:

次要指标

Outcome:

Time up and go

Type:

Secondary indicator

测量时间点:

干预前,干预4周,干预8周

测量方法:

Measure time point of outcome:

baseline, week 4, and week 8

Measure method:

指标中文名:

Zung 抑郁自我评价量表评分

指标类型:

次要指标

Outcome:

Zung Self-Rating Depression Scale Score

Type:

Secondary indicator

测量时间点:

干预前,干预4周,干预8周

测量方法:

Measure time point of outcome:

baseline, week 4, and week 8

Measure method:

指标中文名:

腰椎活动度

指标类型:

次要指标

Outcome:

Lumbar Range of Motion

Type:

Secondary indicator

测量时间点:

干预前,干预4周,干预8周

测量方法:

Measure time point of outcome:

baseline, week 4, and week 8

Measure method:

指标中文名:

Oswestry功能障碍指数

指标类型:

主要指标

Outcome:

Oswestry Disability Index

Type:

Primary indicator

测量时间点:

干预前,干预4周,干预8周

测量方法:

Measure time point of outcome:

baseline, week 4, and week 8

Measure method:

指标中文名:

视觉模拟VAS疼痛评分

指标类型:

主要指标

Outcome:

Visual Analogue Score

Type:

Primary indicator

测量时间点:

干预前,干预4周,干预8周

测量方法:

Measure time point of outcome:

baseline, week 4, and week 8

Measure method:

指标中文名:

简明健康调查量表(SF-36)评分

指标类型:

次要指标

Outcome:

36-Item Short Form Health Survey Score

Type:

Secondary indicator

测量时间点:

干预前,干预4周,干预8周

测量方法:

Measure time point of outcome:

baseline, week 4, and week 8.

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 25 years
最大 Max age 50 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

研究助理使用SPSS 27软件生成的随机数序列

Randomization Procedure (please state who generates the random number sequence and by what method):

A research assistant generated the random number sequence using SPSS 27 software.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

对评估者设盲

Blinding:

Blinding of the evaluator

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

EDC

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2026-05-18 09:06:57